SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001072613-19-000105
Filing Date
2019-02-14
Accepted
2019-02-14 15:10:02
Documents
1
Group Members
ARCH VENTURE FUND VIII OVERAGE, L.P.ARCH VENTURE PARTNERS VIII, L.P.ARCH VENTURE PARTNERS VIII, LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND VIII, L.P. - HOMOLOGY MEDICINES, INC. -- SCHEDULE 13G archviii-homology_13g18289.htm SC 13G 262404
  Complete submission text file 0001072613-19-000105.txt   264085
Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 776-380-6600
ARCH Venture Fund VIII, L.P. (Filed by) CIK: 0001605598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 45 WIGGINS AVE. BEDFORD MA 01730
Business Address 45 WIGGINS AVE. BEDFORD MA 01730 857-305-1825
Homology Medicines, Inc. (Subject) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90433 | Film No.: 19605150
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences